Cargando…

Lactoferrin modification of berberine nanoliposomes enhances the neuroprotective effects in a mouse model of Alzheimer’s disease

Previous studies have shown that berberine has neuroprotective effects against Alzheimer’s disease, including antagonizing tau phosphorylation, and inhibiting acetylcholinesterase activity and neural cell apoptosis. However, its low bioavailability and adverse reactions with conventional administrat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lin, Zhou, Bi-Qiang, Li, Ying-Hong, Jiang, Qian-Qian, Cong, Wei-Hong, Chen, Ke-Ji, Wen, Xiao-Min, Wu, Zheng-Zhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241388/ https://www.ncbi.nlm.nih.gov/pubmed/35799547 http://dx.doi.org/10.4103/1673-5374.344841

Ejemplares similares

Development and characterization of lactoferrin nanoliposome: cellular uptake and stability
por: Guan, Rongfa, et al.
Publicado: (2012)

Co-Delivery of Berberine Chloride and Tariquidar in Nanoliposomes Enhanced Intracellular Berberine Chloride in a Doxorubicin-Resistant K562 Cell Line Due to P-gp Overexpression
por: Vanti, Giulia, et al.
Publicado: (2021)

Enhanced bactericidal potency of nanoliposomes by modification of the fusion activity between liposomes and bacterium
por: Ma, Yufan, et al.
Publicado: (2013)

Neuroprotective effects of berberine in animal models of Alzheimer’s disease: a systematic review of pre-clinical studies
por: Yuan, Ning-Ning, et al.
Publicado: (2019)

Nanoliposomes as a Therapeutic Tool for Alzheimer’s Disease
por: Ordóñez-Gutiérrez, Lara, et al.
Publicado: (2020)

Salivary Lactoferrin Expression in a Mouse Model of Alzheimer’s Disease
por: Antequera, Desiree, et al.
Publicado: (2021)

Mercury-induced neurotoxicity and neuroprotective effects of berberine
por: Moneim, Ahmed E. Abdel
Publicado: (2015)

Berberine: A Potential Multipotent Natural Product to Combat Alzheimer’s Disease
por: Ji, Hong-Fang, et al.
Publicado: (2011)

Neuroprotective Properties of Berberine: Molecular Mechanisms and Clinical Implications
por: Tian, Erjie, et al.
Publicado: (2023)

Molecular Basis of Inhibitory Activities of Berberine against Pathogenic Enzymes in Alzheimer's Disease
por: Ji, Hong-Fang, et al.
Publicado: (2012)

Role of berberine in Alzheimer’s disease
por: Cai, Zhiyou, et al.
Publicado: (2016)

Lactoferrin: neuroprotection against Parkinson's disease and secondary molecule for potential treatment
por: Eker, Furkan, et al.
Publicado: (2023)

Lactoferrin-modified rotigotine nanoparticles for enhanced nose-to-brain delivery: LESA-MS/MS-based drug biodistribution, pharmacodynamics, and neuroprotective effects
por: Yan, Xiuju, et al.
Publicado: (2018)

Nose-to-brain delivery of self-assembled curcumin-lactoferrin nanoparticles: Characterization, neuroprotective effect and in vivo pharmacokinetic study
por: Li, Linghui, et al.
Publicado: (2023)

Neuroprotective Effects of Spinosin on Recovery of Learning and Memory in a Mouse Model of Alzheimer’s Disease
por: Xu, Fanxing, et al.
Publicado: (2019)

Preparation and Evaluation of Antidiabetic Agents of Berberine Organic Acid Salts for Enhancing the Bioavailability
por: Cui, Hong-Xin, et al.
Publicado: (2018)

Facile Synthesis of Phosphatidyl Saccharides for Preparation of Anionic Nanoliposomes with Enhanced Stability
por: Song, Shuang, et al.
Publicado: (2013)

Neuroprotective Role of Lactoferrin during Early Brain Development and Injury through Lifespan
por: Schirmbeck, Gabriel Henrique, et al.
Publicado: (2022)

Berberine Rescues D-Ribose-Induced Alzheimer‘s Pathology via Promoting Mitophagy
por: Wang, Chuanling, et al.
Publicado: (2023)

Nonoxynol-9 berberine plural gel has little effect on expression of SLPI, SP-D and lactoferrin in mice’s vagina
por: Yuan, Qiao, et al.
Publicado: (2013)

Decreased salivary lactoferrin levels are specific to Alzheimer's disease
por: González-Sánchez, Marta, et al.
Publicado: (2020)

The binding of human lactoferrin to mouse peritoneal cells
Publicado: (1976)

Current Evidence and Future Directions of Berberine Intervention in Depression
por: Zhu, Wen-Qian, et al.
Publicado: (2022)

Simvastatin nanoliposome induces myocardial and hepatic toxicities due to its absorption enhancement in mice
por: Tuerdi, Nuerbiye, et al.
Publicado: (2020)

Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer’s Disease Patients
por: Bartolomé, Fernando, et al.
Publicado: (2022)

Preparation of Benzothiazolyl-Decorated Nanoliposomes
por: Mourtas, Spyridon, et al.
Publicado: (2019)

Folate-Targeted Nanoliposomal Chemophototherapy
por: Chitgupi, Upendra, et al.
Publicado: (2023)

Neuroprotection by cyclodextrin in cell and mouse models of Alzheimer disease
por: Yao, Jiaqi, et al.
Publicado: (2012)

Effect of Membrane Surface Modification Using Chitosan Hydrochloride and Lactoferrin on the Properties of Astaxanthin-Loaded Liposomes
por: Qiang, Mengdan, et al.
Publicado: (2020)

M860, a Monoclonal Antibody against Human Lactoferrin, Enhances Tumoricidal Activity of Low Dosage Lactoferrin via Granzyme B Induction
por: Li, Ya, et al.
Publicado: (2019)

Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2019)

Salivary lactoferrin as biomarker for Alzheimer's disease: Brain‐immunity interactions
por: Bermejo‐Pareja, Félix, et al.
Publicado: (2020)

Implication of salivary lactoferrin and periodontal-mediated infections in Alzheimer’s disease
por: Municio, Cristina, et al.
Publicado: (2023)

Modification by SUMOylation Controls Both the Transcriptional Activity and the Stability of Delta-Lactoferrin
por: Escobar-Ramirez, Adelma, et al.
Publicado: (2015)

Berberine confers neuroprotection in coping with focal cerebral ischemia by targeting inflammatory cytokines
por: Maleki, Solmaz Nasseri, et al.
Publicado: (2018)

Micronutrients encapsulation in enhanced nanoliposomal carriers by a novel preparative technology
por: Dalmoro, Annalisa, et al.
Publicado: (2019)

The Quest to Enhance the Efficacy of Berberine for Type-2 Diabetes and Associated Diseases: Physicochemical Modification Approaches
por: Habtemariam, Solomon
Publicado: (2020)

Enhanced Antitumor Efficacy and Reduced Systemic Toxicity of Sulfatide-Containing Nanoliposomal Doxorubicin in a Xenograft Model of Colorectal Cancer
por: Lin, Jia, et al.
Publicado: (2012)

“Guide” of muscone modification enhanced brain‐targeting efficacy and anti‐glioma effect of lactoferrin modified DTX liposomes
por: Qi, Na, et al.
Publicado: (2022)

A New Therapeutic Candidate for Cardiovascular Diseases: Berberine
por: Cai, Yun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s3apb51si6nvkajugjphgdj18k